Synthesis of novel MPTP analogs as potential monoamine oxidase B (MAO-B) inhibitors

Area of Science:

• Biochemistry
• Enzyme kinetics
• Neuroscience

Background:

• 1-methyl-4-phenyl-1,2,3,6-tetahydropyridine (MPTP) is a known substrate and weak inhibitor of monoamine oxidase B (MAO-B).
• MAO-B is a flavoenzyme implicated in neurological processes and diseases.

Purpose of the Study:

• To synthesize and evaluate novel MPTP analogs as potential mechanism-based inactivators of MAO-B.
• To investigate the structure-activity relationships of MPTP analogs at the N and C(4) positions for MAO-B inhibition.

Main Methods:

• Synthesis of MPTP analogs with various substituents (allyl, propargyl, ethenyl, ethynyl, cyclobutyl) at N or C(4) positions.
• Enzyme inhibition assays using purified beef liver MAO-B.
• Kinetic analysis of time- and concentration-dependent inhibition.

Main Results:

• C(4)-substituted MPTP analogs showed weak or no significant enzyme inhibition, though some were good substrates.
• The N-substituted analog, 4-phenyl-1-propargyl, demonstrated potent, time- and concentration-dependent inhibition of MAO-B.
• Results suggest a mechanism-based inactivation pathway and provide insights into MAO-B active site sterics.

Conclusions:

• The 4-phenyl-1-propargyl MPTP analog is a promising mechanism-based inactivator of MAO-B.
• The C(4) position of the tetrahydropyridine ring in MPTP analogs appears to lack a reactive nucleophilic group within the MAO-B active site.
• These findings contribute to the design of targeted MAO-B inhibitors.